RegularLabs Users Anywhere Extension up to 3.0.0 information disclosure
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.3 | $0-$5k | 2.47 |
Summary
A vulnerability classified as problematic has been found in RegularLabs Users Anywhere Extension up to 3.0.0. This affects an unknown part. The manipulation leads to information disclosure. This vulnerability is uniquely identified as CVE-2026-102801. The attack is possible to be carried out remotely. No exploit exists.
Details
A vulnerability was found in RegularLabs Users Anywhere Extension up to 3.0.0 and classified as problematic. This issue affects some unknown processing. The manipulation with an unknown input leads to a information disclosure vulnerability. Using CWE to declare the problem leads to CWE-200. The product exposes sensitive information to an actor that is not explicitly authorized to have access to that information. Impacted is confidentiality. The summary by CVE is:
Joomla Extension - regularlabs.com - Exposure of Sensitive Information to Unauthorized Actor in Users Anywhere extension for Joomla < 3.0.1 - An administrator can disable output of user email addresses or usernames in Users Anywhere. In affected code, attributes supplied inside a {user} or [email] / [username] tag can change those plugin settings for that render. For example, [email allow_output_email="1"] can display an email address even when Allow output of email is set to No. This bypasses the personal-data output setting; it does not bypass a separate policy that disallows Users Anywhere tags from the content source altogether.
It is possible to read the advisory at regularlabs.com. The identification of this vulnerability is CVE-2026-102801 since 09/29/2026. The exploitation is known to be easy. The attack may be initiated remotely. No form of authentication is needed for a successful exploitation. It demands that the victim is doing some kind of user interaction. The technical details are unknown and an exploit is not publicly available. The attack technique deployed by this issue is T1592 according to MITRE ATT&CK.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
Product
Vendor
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CNA CVSS-B Score: 🔒
CNA CVSS-BT Score: 🔒
CNA Vector: 🔒
CVSSv3
VulDB Meta Base Score: 4.3VulDB Meta Temp Score: 4.3
VulDB Base Score: 4.3
VulDB Temp Score: 4.3
VulDB Vector: 🔒
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Information disclosureCWE: CWE-200 / CWE-284 / CWE-266
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
09/29/2026 CVE reserved11/02/2026 Advisory disclosed
11/02/2026 VulDB entry created
11/02/2026 VulDB entry last update
Sources
Advisory: regularlabs.comStatus: Not defined
CNA: Joomla
CVE: CVE-2026-102801 (🔒)
GCVE (CVE): GCVE-0-2026-102801
GCVE (VulDB): GCVE-100-429827
Entry
Created: 11/02/2026 14:43Changes: 11/02/2026 14:43 (63)
Complete: 🔍
Cache ID: 216::103
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.